Reducing belly fat with an injection: CBL-514 trial
Treatments studied
This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is between 18.5 and 30 (a normal to slightly overweight range), and you weigh at least 50 kg (about 110 pounds).
- You have moderate or severe extra fat in the belly area.
- You feel dissatisfied with your belly fat (for example, extremely dissatisfied, dissatisfied, or slightly dissatisfied).
- You are generally healthy and have no conditions that would make the injections risky, like bleeding disorders, uncontrolled diabetes, or heart problems.
- You are not currently on weight-loss medications or programs, and you have not had other procedures in the belly area that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable treatment, CBL-514, to reduce belly fat. It may help people who have stubborn abdominal fat that doesn't go away with diet and exercise.
This study checks whether the fat-reducing effects from the earlier treatment last over time, and whether the treatment is safe to use long-term. It is only for people who already took part in the first part of this study.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
This study tests an injection called CBL-514 that may help reduce belly fat. It is for adults with extra abdominal fat who want a non-surgical option.
This trial tests a new non-invasive device to reduce fat in the belly and sides (love handles). It may help people who have stubborn fat in these areas despite a stable weight.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
Hear when a new Subcutaneous Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.